Unique Access Medical is Now Welcoming Multiple Sclerosis Patients for an Innovative Treatment

Unique Access Medical (UAM) is pleased to announce our new venture, in collaboration with Autologous Stem Cell (ASC) Treatment, into the development of a potential treatment for Multiple Sclerosis. Our highly experienced collaborator, who is based in Australia, is a Regenerative Treatment facilitator that has lawfully carried out more than 400 cellular treatments in the past 6 years. ASC Treatment’s innovative technology avoids any genetic manipulation and utilises the patient’s own blood to culture cells, making the method extremely safe and effective.

In an attempt to give hope to all patients with Multiple Sclerosis, Unique Access Medical and ASC Treatment strives to provide patients suffering from Multiple Sclerosis with the most innovative Cellular Treatment. With a strong confidence in the utilised cell’s ability to regenerate and repair the damaged neurons, slow down the progression of the disease, and improve the patient’s quality of lives, UAM is happy to support the development of the project and provide access to a potential treatment for all patients in need.

We are now recruiting up to 10 patients with Multiple Sclerosis (MS) to undergo this new treatment plan, which will be carried out in Bangkok during February to March 2018. Please hurry up and secure a spot for yourself or your loved-one to redeem a special discount provided only on a first come first serve basis.

To learn more about the treatment and to book a free consultation with our medical experts, please reach us at [email protected]